 | ALT.O - Altimmune Inc Profile | Reuters reuters.com - April 19 at 2:15 AM |
 | Altimmune, Inc. (NASDAQ:ALT) Given Consensus Rating of "Buy" by Analysts americanbankingnews.com - April 18 at 2:44 AM |
 | $2.19 Million in Sales Expected for Altimmune, Inc. (NASDAQ:ALT) This Quarter americanbankingnews.com - April 17 at 3:42 AM |
 | Short Interest in Altimmune, Inc. (NASDAQ:ALT) Grows By 82.5% americanbankingnews.com - April 17 at 1:00 AM |
 | Altimmune, Inc. (NASDAQ:ALT) Expected to Announce Earnings of -$0.39 Per Share americanbankingnews.com - April 15 at 6:08 AM |
 | Could AstraZeneca's Nasal COVID Vaccine Development Zap Altimmune's Prospects? - Motley Fool fool.com - April 10 at 6:13 AM |
 | Estimating The Intrinsic Value Of Altimmune, Inc. (NASDAQ:ALT) - Nasdaq nasdaq.com - April 7 at 5:15 AM |
 | A Look At The Fair Value Of Altimmune, Inc. (NASDAQ:ALT) - Yahoo Finance finance.yahoo.com - April 3 at 9:21 AM |
 | A Look At The Fair Value Of Altimmune, Inc. (NASDAQ:ALT) finance.yahoo.com - April 3 at 9:21 AM |
 | Altimmune highlights safety of anthrax vaccine candidate with early-stage results - Seeking Alpha seekingalpha.com - April 1 at 5:58 PM |
|
 | Altimmune (ALT) Reports Data from its Phase 1b Clinical Trial of NasoShield - StreetInsider.com streetinsider.com - April 1 at 2:36 PM |
 | Altimmune's Anthrax Vaccine Candidate Shows Early Safety, Immunogenicity In Healthy Volunteers - Yahoo Finance finance.yahoo.com - April 1 at 2:36 PM |
 | Altimmune Reports Data from its Phase 1b Clinical Trial of NasoShield™ - Yahoo Finance finance.yahoo.com - April 1 at 2:36 PM |
 | Altimmune's Anthrax Vaccine Candidate Shows Early Safety, Immunogenicity In Healthy Volunteers - Benzinga benzinga.com - April 1 at 9:35 AM |
 | Altimmune Reports Data from its Phase 1b Clinical Trial of NasoShield™ - GlobeNewswire globenewswire.com - April 1 at 9:35 AM |
 | BRIEF-Altimmune Reports Data From Its Phase 1B Clinical Trial Of Nasoshield msn.com - April 1 at 7:56 AM |
 | Altimmune Reports Data from its Phase 1b Clinical Trial of NasoShield™ finance.yahoo.com - April 1 at 7:55 AM |
 | Altimmune Stock Is Believed To Be Significantly Overvalued - Yahoo Finance finance.yahoo.com - March 27 at 4:25 AM |
 | AstraZeneca’s COVID-19 nasal spray sparks interest in Altimmune - Seeking Alpha seekingalpha.com - March 26 at 6:23 PM |
 | Altimmune Partners with Summit Biosciences to Produce a Multidose Nasal Spray Presentation of its AdCOVID(TM) Vaccine Candidate marketwatch.com - March 23 at 8:01 PM |
 | Altimmune Partners with Summit Biosciences to Produce a Multidose Nasal Spray Presentation of its AdCOVID™ Vaccine Candidate - GlobeNewswire globenewswire.com - March 22 at 7:36 AM |
 | Altimmune Partners with Summit Biosciences to Produce a Multidose Nasal Spray Presentation of its AdCOVID™ Vaccine Candidate finance.yahoo.com - March 22 at 7:36 AM |
 | Is Altimmune a Buy? nasdaq.com - March 20 at 5:53 PM |
 | Is Altimmune a Buy? - Motley Fool fool.com - March 20 at 7:52 AM |
 | AdCOVID™, Altimmune’s Single Dose, Intranasal COVID-19 Vaccine Candidate, Prevents SARS-CoV-2-induced Disease and Blocks Viral Replication in Preclinical Studies of SARS-CoV-2 Infection - Yahoo Finance finance.yahoo.com - March 17 at 10:50 PM |
 | Altimmune's Shares Are Trading Higher On Intranasal COVID-19 Vaccine Candidate's Promising Action In Animal Studies - Benzinga benzinga.com - March 16 at 3:16 PM |
 | Altimmune's Shares Are Trading Higher On Intranasal COVID-19 Vaccine Candidate's Promising Action In Animal Studies - Yahoo Finance finance.yahoo.com - March 15 at 11:50 PM |
 | Altimmune shares rise on encouraging COVID-19 vaccine data in mouse model - Seeking Alpha seekingalpha.com - March 15 at 1:28 PM |
|
 | AdCOVID™, Altimmune's Single Dose, Intranasal COVID-19 Vaccine Candidate, Prevents SARS-CoV-2-induced Disease and Blocks Viral Replication in Preclinical Studies of SARS-CoV-2 Infection - GlobeNewswire globenewswire.com - March 15 at 9:22 AM |
 | Altimmune's Shares Are Trading Higher On Intranasal COVID-19 Vaccine Candidate's Promising Action In Animal Studies markets.businessinsider.com - March 15 at 8:26 AM |
 | AdCOVID™, Altimmune’s Single Dose, Intranasal COVID-19 Vaccine Candidate, Prevents SARS-CoV-2-induced Disease and Blocks Viral Replication in Preclinical Studies of SARS-CoV-2 Infection finance.yahoo.com - March 15 at 8:26 AM |
 | Altimmune Extends Lonza Partnership To Support Production Of AdCOVID - Yahoo Finance finance.yahoo.com - March 14 at 6:34 PM |
 | Altimmune Extends Lonza Partnership To Support Production Of AdCOVID finance.yahoo.com - March 14 at 7:58 AM |
 | Lonza to commission Houston suite to supply Altimmune's COVID-19 vaccine candidate - Reuters reuters.com - March 13 at 10:51 AM |
 | Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza - GlobeNewswire globenewswire.com - March 13 at 10:51 AM |
 | Altimmune (ALT) Expands AdCOVID Manufacturing Collaboration with Lonza - StreetInsider.com streetinsider.com - March 13 at 2:53 AM |
 | UPDATE 1-Lonza to commission Houston suite to supply Altimmune's COVID-19 vaccine candidate - Yahoo Finance finance.yahoo.com - March 12 at 9:53 PM |
 | Altimmune expands AdCOVID manufacturing pact with Lonza - Seeking Alpha seekingalpha.com - March 12 at 9:13 PM |
 | Altimmune Shares Are Trading Higher On Expanded Manufacturing Pact With Lonza finance.yahoo.com - March 12 at 3:39 PM |
 | Lonza to commission Houston suite to supply Altimmune's COVID-19 vaccine candidate msn.com - March 12 at 3:39 PM |
 | Altimmune expands manufacturing deal for experimental Covid-19 vaccine bizjournals.com - March 12 at 3:39 PM |
 | Why ContraFect, Evoke, Altimmune, Novavax Are Moving Friday markets.businessinsider.com - March 12 at 3:39 PM |
 | Why ContraFect, Evoke, Altimmune, Novavax Are Moving Friday - Benzinga benzinga.com - March 12 at 2:42 PM |
 | Altimmune Shares Are Trading Higher On Expanded Manufacturing Pact With Lonza - Benzinga benzinga.com - March 12 at 9:15 AM |
 | Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza - Yahoo Finance finance.yahoo.com - March 12 at 9:15 AM |
 | Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza finance.yahoo.com - March 12 at 9:15 AM |
 | Altimmune Joins Rank Of Stocks With RS Ratings Over 90 finance.yahoo.com - March 10 at 12:39 PM |
 | Altimmune to Present at Upcoming Conferences - Yahoo Finance finance.yahoo.com - March 9 at 6:09 PM |
 | Altimmune Joins Rank Of Stocks With RS Ratings Over 90 - Investor's Business Daily investors.com - March 9 at 1:09 PM |
 | Altimmune to Present at Upcoming Conferences Nasdaq:ALT - GlobeNewswire globenewswire.com - March 8 at 6:13 PM |